Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)

SHA:603520 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	411.42	603.35	565.13	661.56	775.74	799.49
Trading Asset Securities	-	-	0.02	0.88	70.16	130.76
Cash & Short-Term Investments	411.42	603.35	565.16	662.44	845.9	930.25
Cash Growth	-21.33%	6.76%	-14.69%	-21.69%	-9.07%	114.45%
Accounts Receivable	694	437.16	492.44	711.18	663.79	429.56
Other Receivables	7.13	4.27	4.82	8.31	12.77	2.7
Receivables	701.13	441.42	497.26	719.49	676.56	432.26
Inventory	1,088	1,105	1,148	738.58	517.59	536.54
Other Current Assets	106.05	80.77	54.07	51.12	21.76	34.52
Total Current Assets	2,306	2,231	2,265	2,172	2,062	1,934
Property, Plant & Equipment	2,971	2,866	2,345	2,189	1,791	1,604
Long-Term Investments	155.76	156.13	129.42	135.94	159.55	99.59
Goodwill	404.96	404.96	404.96	404.96	519.71	519.71
Other Intangible Assets	298.48	302.55	311.93	310.73	231.17	197.9
Long-Term Deferred Tax Assets	38.84	36.96	21.72	22.5	14.39	5.48
Long-Term Deferred Charges	14.8	13.52	19.23	39.05	41.18	25.44
Other Long-Term Assets	38.21	34.92	19.14	28.62	77.03	20.57
Total Assets	6,228	6,046	5,516	5,302	4,895	4,406
Accounts Payable	615.3	532.86	508.1	540.63	590.94	295.93
Accrued Expenses	20.32	93.76	72.52	58.27	57.4	46.8
Short-Term Debt	1,500	1,441	1,855	1,689	926.92	827.92
Current Portion of Long-Term Debt	488	545.02	465.23	416.29	232.75	-
Current Portion of Leases	-	0.34	1.7	1.56	1.56	-
Current Income Taxes Payable	22.97	7.27	0.71	0.73	28.03	19.63
Current Unearned Revenue	37.99	4.45	10.92	10.44	5.1	0.19
Other Current Liabilities	82.93	53.07	17.19	43.07	43.35	335.26
Total Current Liabilities	2,768	2,677	2,931	2,760	1,886	1,526
Long-Term Debt	628.27	537.28	734.45	673.85	746.55	992.95
Long-Term Leases	84.32	94.57	0.02	1.54	-	-
Long-Term Unearned Revenue	98.73	101.95	91.66	94.41	43.35	22.94
Long-Term Deferred Tax Liabilities	-	-	-	1.38	-	-
Other Long-Term Liabilities	-	-	-	-	4.88	-
Total Liabilities	3,579	3,411	3,758	3,531	2,681	2,542
Common Stock	438.41	438.41	342.51	342.91	245.02	244.9
Additional Paid-In Capital	1,643	1,643	810.74	813.79	1,141	977.66
Retained Earnings	543.55	529.21	600.23	624.25	822.53	629.34
Treasury Stock	-	-	-	-24.64	-27.75	-26.07
Comprehensive Income & Other	17.87	17.46	-0.88	8.93	-5.51	-2.34
Total Common Equity	2,643	2,628	1,753	1,765	2,175	1,824
Minority Interest	6.21	6.29	6.3	5.97	39.56	41.21
Shareholders' Equity	2,649	2,634	1,759	1,771	2,215	1,865
Total Liabilities & Equity	6,228	6,046	5,516	5,302	4,895	4,406
Total Debt	2,701	2,618	3,056	2,782	1,908	1,821
Net Cash (Debt)	-2,290	-2,014	-2,491	-2,120	-1,062	-890.62
Net Cash Per Share	-5.07	-4.92	-7.32	-6.15	-3.08	-2.66
Filing Date Shares Outstanding	438.41	438.41	342.51	342.4	342.15	341.94
Total Common Shares Outstanding	438.41	438.41	342.51	342.4	342.15	341.94
Working Capital	-461.57	-446.72	-666.63	-588.15	175.75	407.83
Book Value Per Share	6.03	5.99	5.12	5.16	6.36	5.33
Tangible Book Value	1,939	1,921	1,036	1,050	1,424	1,106
Tangible Book Value Per Share	4.42	4.38	3.02	3.07	4.16	3.23
Buildings	-	1,286	1,174	1,018	951.68	924.44
Machinery	-	1,915	1,739	124.38	1,254	1,183
Construction In Progress	-	871.31	453.09	635.52	371.47	152.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.